STOCK TITAN

Cardinal Health, Inc. - CAH STOCK NEWS

Welcome to our dedicated page for Cardinal Health news (Ticker: CAH), a resource for investors and traders seeking the latest updates and insights on Cardinal Health stock.

Cardinal Health, Inc. (NYSE: CAH) is a global leader in integrated healthcare services and products. With nearly 100 years of experience, the company stands as a pillar in the healthcare industry, ranking among the top 25 on the Fortune 500 list. Cardinal Health offers a comprehensive suite of services that cater to hospital systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices worldwide.

Operating through two main segments—Pharmaceuticals and Medical—Cardinal Health provides clinically-proven medical products and pharmaceuticals, alongside cost-effective solutions that enhance supply chain efficiency. The company is a major distributor of branded, generic, and specialty pharmaceutical products to a wide array of clients, including retail chains, independent pharmacies, hospital networks, and healthcare providers.

Recently, Cardinal Health reported strong financial results for Q2 FY2024, with a 12% increase in revenue to $57.4 billion. The company also saw significant growth in both its Pharmaceutical and Medical segments, driven by robust sales of brand and specialty pharmaceuticals, as well as improvements in at-Home Solutions and Global Medical Products and Distribution. CEO Jason Hollar highlighted the company's operational execution and strategic priorities, which include tech-enabled specialty acquisitions and a focus on supply chain resiliency.

Cardinal Health is also committed to sustainability and corporate responsibility. The company recently released its Fiscal 2023 Environmental, Social and Governance (ESG) Report, emphasizing long-term value creation through sustainable practices. The company has received approval from the Science Based Targets initiative (SBTi) for its ambitious greenhouse gas (GHG) emissions reduction targets. By FY2023, Cardinal Health had already reduced its Scope 1 and 2 emissions by 13% from a FY2019 base year.

In terms of infrastructure, Cardinal Health is expanding its logistics capabilities. The company has commenced construction on a new 350,000 square-foot Consumer Health Logistics Center in Columbus, Ohio, designed to support the distribution of over-the-counter consumer health products. This facility, expected to be operational by Summer 2025, will create approximately 100 new jobs and enhance Cardinal Health's supply chain agility.

Despite challenges such as the non-renewal of its pharmaceutical distribution contracts with OptumRx, Cardinal Health remains resilient. The company reaffirmed its fiscal 2024 non-GAAP diluted EPS guidance and is confident in its long-term growth targets.

For more information, visit cardinalhealth.com and follow @cardinalhealth on Twitter.

Rhea-AI Summary

Cardinal Health reported an 11% revenue increase to $47.1 billion for Q4 FY22, with GAAP operating earnings of $36 million impacted by a $303 million non-cash impairment charge. Non-GAAP operating earnings rose 41% to $450 million, resulting in a non-GAAP diluted EPS of $1.05. The company generated $3.1 billion in operating cash flow for FY22 and expects non-GAAP EPS guidance for FY23 between $5.05 and $5.40. Leadership changes were announced, with Jason Hollar becoming CEO, effective September 2022, as part of ongoing strategic improvements.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.18%
Tags
-
Rhea-AI Summary

Cardinal Health (NYSE: CAH) announced a leadership change on August 11, 2022, with Jason Hollar succeeding Mike Kaufmann as CEO effective September 1, 2022. Hollar, previously the Chief Financial Officer since May 2020, is expected to steer the company towards long-term growth. Patricia English will serve as interim CFO during the transition. Kaufmann expressed gratitude for his time as CEO and confidence in Hollar's leadership. The transition aims to ensure continuity and leverage Hollar's financial expertise to enhance value for shareholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.18%
Tags
management
-
Rhea-AI Summary

Cardinal Health (NYSE: CAH) has appointed Michelle Greene as its new chief information officer, effective August 1, 2022. Greene, who joined Cardinal Health in 2021 as SVP of EIT for the Pharmaceutical Segment, will report directly to CEO Mike Kaufmann and join the executive committee. With a strong background in IT leadership across various industries, Greene aims to drive innovation within the company. Her past experience includes roles at Masco Corporation and Johnson Controls. She holds a master's degree in Information Science from Florida State University.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.28%
Tags
none
Rhea-AI Summary

The Court has authorized a Summary Notice regarding a proposed $124 million settlement of a stockholder derivative action against Cardinal Health. The settlement aims to resolve claims made in In re Cardinal Health, Inc. Derivative Litig. The Court will hold a Settlement Hearing on October 4, 2022, to evaluate the Settlement's fairness and reasonableness. Stockholders as of May 25, 2022, can object by September 13, 2022. Importantly, benefits from this Settlement will benefit the company, not individual stockholders directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.51%
Tags
none
-
Rhea-AI Summary

Cardinal Health (NYSE: CAH) will announce its fourth-quarter and year-end financial results for fiscal year 2022 on August 11, before the market opens. A webcast discussing these results is set for 8:30 a.m. Eastern the same day. The financial results are anticipated to provide insights into the company's performance in various healthcare sectors, which include pharmaceuticals and medical products. For details, visit Cardinal Health's Investor Relations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.21%
Tags
-
Rhea-AI Summary

Cardinal Health has acquired the Bendcare group purchasing organization (CPO-GPO) and made a minority investment in its management services organization (MSO) to enhance its Cornerstone Rheumatology™ GPO. This strategic move allows Cardinal Health to provide innovative solutions and robust specialty drug access to over 1,300 rheumatology providers nationwide. Although financial terms remain undisclosed, the acquisition aims to improve technology solutions and distribution for specialty practices, reinforcing Cardinal Health's position in the healthcare market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.75%
Tags
Rhea-AI Summary

Cardinal Health (NYSE: CAH) launched an innovative Reserved Inventory Program aimed at improving inventory management for respiratory diagnostics in anticipation of the upcoming flu, strep, and RSV seasons. This program, tailored to individual labs and health systems, utilizes historical data to predict inventory needs, thereby alleviating supply challenges faced during previous respiratory seasons. Feedback from pilot participants indicates a significant reduction in inventory constraints and a high satisfaction rate. The program promises to deliver consistent supply and reduce delays in respiratory testing products.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.24%
Tags
none
-
Rhea-AI Summary

Cardinal Health released new research indicating severe burnout among oncologists, with nearly 90% reporting emotional exhaustion. Over half of oncologists feel more stressed post-COVID-19, and 30% have considered early retirement due to stress. The study highlights barriers like prior authorizations affecting patient care, with 90% citing it as a significant hurdle. Cardinal Health has invested $2.6 million in mental health initiatives and aims to support oncologists in managing stress to mitigate the projected physician shortage by 2033.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.25%
Tags
none
-
Rhea-AI Summary

Cardinal Health (NYSE: CAH) has announced a new distribution center in Grove City, Ohio, enhancing its at-Home Solutions business. This facility, measuring 208,144 square feet, is designed with advanced logistics technology, including robotic storage and the Kinaxis® RapidResponse® platform. It aims to support the growing demand for home healthcare, creating approximately 100 jobs by November 2022. This investment is part of a multi-year strategy to expand Cardinal Health's distribution network in Central Ohio, improving operational efficiencies and customer service.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.68%
Tags
none
Rhea-AI Summary

Cardinal Health (NYSE: CAH) has announced a quarterly dividend of $0.4957 per share, approved by its Board of Directors. This dividend will be paid on July 15, 2022, to shareholders on record as of July 1, 2022. With a robust operational presence in over 30 countries and approximately 44,000 employees, Cardinal Health remains a crucial player in healthcare distribution and services. This dividend reflects the company's commitment to returning value to shareholders while maintaining a strong position in the healthcare sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.27%
Tags
dividends

FAQ

What is the current stock price of Cardinal Health (CAH)?

The current stock price of Cardinal Health (CAH) is $118.28 as of December 20, 2024.

What is the market cap of Cardinal Health (CAH)?

The market cap of Cardinal Health (CAH) is approximately 28.7B.

What services does Cardinal Health offer?

Cardinal Health provides integrated healthcare services and products, including clinically-proven medical products, pharmaceuticals, and supply chain solutions for hospital systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices.

How did Cardinal Health perform in Q2 FY2024?

Cardinal Health reported a 12% increase in revenue to $57.4 billion, with strong growth in both Pharmaceutical and Medical segments. Non-GAAP diluted EPS increased 38% to $1.82.

What is Cardinal Health's approach to sustainability?

Cardinal Health is committed to sustainability and corporate responsibility, as evidenced by its Fiscal 2023 ESG Report and approval from the Science Based Targets initiative (SBTi) for its greenhouse gas (GHG) emissions reduction targets.

What are Cardinal Health's main business segments?

Cardinal Health operates through two main segments: Pharmaceuticals and Medical. The Pharmaceuticals segment focuses on the distribution of branded, generic, and specialty pharmaceutical products, while the Medical segment provides medical-surgical products and equipment.

What recent infrastructure developments has Cardinal Health announced?

Cardinal Health has begun construction on a 350,000 square-foot Consumer Health Logistics Center in Columbus, Ohio, scheduled to be operational by Summer 2025. This facility will support the distribution of over-the-counter consumer health products.

How many employees does Cardinal Health have?

Cardinal Health employs more than 48,000 people globally, with operations in over 30 countries.

What are Cardinal Health's fiscal 2024 guidance and expectations?

Cardinal Health raised its fiscal 2024 guidance range for non-GAAP diluted earnings per share to $7.30 to $7.40. The company also expects 8.5% to 9.5% growth in Pharmaceutical and Specialty Solutions segment profit.

How is Cardinal Health addressing supply chain efficiency?

Cardinal Health continuously works on enhancing supply chain efficiency through advanced inventory management systems and supply chain resiliency initiatives. The new Consumer Health Logistics Center will further improve its capabilities.

What impact will the non-renewal of OptumRx contracts have on Cardinal Health?

Despite the non-renewal of its contracts with OptumRx, Cardinal Health expects to partially offset the impact through new customer wins, specialty growth, and other actions. The company has reaffirmed its long-term growth targets.

Where can I find more information about Cardinal Health?

More information about Cardinal Health is available on its website at cardinalhealth.com. You can also follow the company on Twitter @cardinalhealth.

Cardinal Health, Inc.

NYSE:CAH

CAH Rankings

CAH Stock Data

28.72B
241.37M
0.25%
89.55%
2.47%
Medical Distribution
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States of America
DUBLIN